A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal (Q37036723)
Jump to navigation
Jump to search
scientific article published on 27 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal |
scientific article published on 27 May 2008 |
Statements
1 reference
A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal (English)
1 reference
Marian W Fischman
1 reference
Elmer Yu
1 reference
Karen Miotto
1 reference
Evaristo Akerele
1 reference
Ann Montgomery
1 reference
Ahmed Elkashef
1 reference
Robert Walsh
1 reference
Ivan Montoya
1 reference
Joseph Collins
1 reference
Frances McSherry
1 reference
Kathy Boardman
1 reference
David K Davies
1 reference
Charles P O'Brien
1 reference
Walter Ling
1 reference
Herbert Kleber
1 reference
Barbara H Herman
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference